NATIONAL RESEARCH CORP (NRC) Stock Fundamental Analysis
USA - NASDAQ:NRC - US6373722023 - Common Stock
11.61 USD
-0.07 (-0.6%)
11.61 USD
0 (0%)
NRC gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. While NRC has a great profitability rating, there are quite some concerns on its financial health. NRC has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
NRC had positive earnings in the past year.
NRC had a positive operating cash flow in the past year.
NRC had positive earnings in each of the past 5 years.
NRC had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With an excellent Return On Assets value of 12.68%, NRC belongs to the best of the industry, outperforming 98.02% of the companies in the same industry.
NRC's Return On Equity of 84.06% is amongst the best of the industry. NRC outperforms 99.01% of its industry peers.
NRC has a Return On Invested Capital of 20.28%. This is amongst the best in the industry. NRC outperforms 94.06% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NRC is significantly above the industry average of 9.33%.
The last Return On Invested Capital (20.28%) for NRC is well below the 3 year average (37.15%), which needs to be investigated, but indicates that NRC had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.68% | ||
| ROE | 84.06% | ||
| ROIC | 20.28% |
ROA(3y)22.78%
ROA(5y)24%
ROE(3y)62.21%
ROE(5y)57.67%
ROIC(3y)37.15%
ROIC(5y)35.26%
1.3 Margins
With an excellent Profit Margin value of 12.78%, NRC belongs to the best of the industry, outperforming 99.01% of the companies in the same industry.
NRC's Profit Margin has declined in the last couple of years.
NRC has a Operating Margin of 19.88%. This is amongst the best in the industry. NRC outperforms 96.04% of its industry peers.
NRC's Operating Margin has declined in the last couple of years.
The Gross Margin of NRC (60.31%) is better than 81.19% of its industry peers.
NRC's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.88% | ||
| PM (TTM) | 12.78% | ||
| GM | 60.31% |
OM growth 3Y-10.18%
OM growth 5Y-5.95%
PM growth 3Y-11.83%
PM growth 5Y-7.25%
GM growth 3Y-2.32%
GM growth 5Y-1.11%
2. Health
2.1 Basic Checks
NRC has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, NRC has less shares outstanding
Compared to 5 years ago, NRC has less shares outstanding
NRC has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.72 indicates that NRC is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.72, NRC is in line with its industry, outperforming 57.43% of the companies in the same industry.
NRC has a debt to FCF ratio of 8.73. This is a slightly negative value and a sign of low solvency as NRC would need 8.73 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 8.73, NRC is in line with its industry, outperforming 53.47% of the companies in the same industry.
A Debt/Equity ratio of 3.61 is on the high side and indicates that NRC has dependencies on debt financing.
The Debt to Equity ratio of NRC (3.61) is worse than 78.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.61 | ||
| Debt/FCF | 8.73 | ||
| Altman-Z | 2.72 |
ROIC/WACC2.5
WACC8.1%
2.3 Liquidity
NRC has a Current Ratio of 0.70. This is a bad value and indicates that NRC is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of NRC (0.70) is worse than 86.14% of its industry peers.
A Quick Ratio of 0.70 indicates that NRC may have some problems paying its short term obligations.
NRC's Quick ratio of 0.70 is on the low side compared to the rest of the industry. NRC is outperformed by 80.20% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.7 | ||
| Quick Ratio | 0.7 |
3. Growth
3.1 Past
The earnings per share for NRC have decreased strongly by -36.26% in the last year.
NRC shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -3.70% yearly.
NRC shows a decrease in Revenue. In the last year, the revenue decreased by -4.08%.
Measured over the past years, NRC shows a small growth in Revenue. The Revenue has been growing by 2.25% on average per year.
EPS 1Y (TTM)-36.26%
EPS 3Y-10.59%
EPS 5Y-3.7%
EPS Q2Q%-101.82%
Revenue 1Y (TTM)-4.08%
Revenue growth 3Y-1.13%
Revenue growth 5Y2.25%
Sales Q2Q%-2.8%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 15.08, which indicates a correct valuation of NRC.
80.20% of the companies in the same industry are more expensive than NRC, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.42. NRC is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.08 | ||
| Fwd PE | N/A |
4.2 Price Multiples
70.30% of the companies in the same industry are more expensive than NRC, based on the Enterprise Value to EBITDA ratio.
NRC's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 28.87 | ||
| EV/EBITDA | 10.03 |
4.3 Compensation for Growth
The excellent profitability rating of NRC may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.11%, NRC is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.45, NRC pays a better dividend. On top of this NRC pays more dividend than 99.01% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.36, NRC pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.11% |
5.2 History
The dividend of NRC decreases each year by -17.40%.
NRC has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-17.4%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
NRC pays out 62.38% of its income as dividend. This is not a sustainable payout ratio.
NRC's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP62.38%
EPS Next 2YN/A
EPS Next 3YN/A
11.61
-0.07 (-0.6%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners51.36%
Inst Owner Change-0.12%
Ins Owners9.51%
Ins Owner Change10.19%
Market Cap267.73M
Analysts45
Price TargetN/A
Short Float %3.56%
Short Ratio4.27
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.11% |
Yearly Dividend0.48
Dividend Growth(5Y)-17.4%
DP62.38%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.08 | ||
| Fwd PE | N/A | ||
| P/S | 1.91 | ||
| P/FCF | 28.87 | ||
| P/OCF | 12.56 | ||
| P/B | 12.55 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.03 |
EPS(TTM)0.77
EY6.63%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.4
FCFY3.46%
OCF(TTM)0.92
OCFY7.96%
SpS6.08
BVpS0.92
TBVpS-2.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.68% | ||
| ROE | 84.06% | ||
| ROCE | 26.45% | ||
| ROIC | 20.28% | ||
| ROICexc | 21.34% | ||
| ROICexgc | 67.64% | ||
| OM | 19.88% | ||
| PM (TTM) | 12.78% | ||
| GM | 60.31% | ||
| FCFM | 6.61% |
ROA(3y)22.78%
ROA(5y)24%
ROE(3y)62.21%
ROE(5y)57.67%
ROIC(3y)37.15%
ROIC(5y)35.26%
ROICexc(3y)44.09%
ROICexc(5y)48.46%
ROICexgc(3y)273.96%
ROICexgc(5y)N/A
ROCE(3y)48.46%
ROCE(5y)46%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-21.97%
ROICexc growth 5Y-12.09%
OM growth 3Y-10.18%
OM growth 5Y-5.95%
PM growth 3Y-11.83%
PM growth 5Y-7.25%
GM growth 3Y-2.32%
GM growth 5Y-1.11%
F-Score5
Asset Turnover0.99
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.61 | ||
| Debt/FCF | 8.73 | ||
| Debt/EBITDA | 2.25 | ||
| Cap/Depr | 189.66% | ||
| Cap/Sales | 8.58% | ||
| Interest Coverage | 9.03 | ||
| Cash Conversion | 62.23% | ||
| Profit Quality | 51.72% | ||
| Current Ratio | 0.7 | ||
| Quick Ratio | 0.7 | ||
| Altman-Z | 2.72 |
F-Score5
WACC8.1%
ROIC/WACC2.5
Cap/Depr(3y)236.79%
Cap/Depr(5y)169.97%
Cap/Sales(3y)9.3%
Cap/Sales(5y)6.92%
Profit Quality(3y)77.54%
Profit Quality(5y)88.07%
High Growth Momentum
Growth
EPS 1Y (TTM)-36.26%
EPS 3Y-10.59%
EPS 5Y-3.7%
EPS Q2Q%-101.82%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.08%
Revenue growth 3Y-1.13%
Revenue growth 5Y2.25%
Sales Q2Q%-2.8%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-29.67%
EBIT growth 3Y-11.19%
EBIT growth 5Y-3.83%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-56.39%
FCF growth 3Y-22.27%
FCF growth 5Y-11.96%
OCF growth 1Y-38.68%
OCF growth 3Y-9.26%
OCF growth 5Y-3.29%